Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UBQLN2 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-09 |
mRNA | ALMS1 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-09 |
mRNA | POLA1 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-09 |
mRNA | ITGA2 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | RFC4 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-09 |
mRNA | TMEM105 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | CCDC117 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-09 |
mRNA | HSF2 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-09 |
mRNA | WDCP | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-09 |
mRNA | TNFRSF1B | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |